← Leaderboards
Tony Ward
Gpb Scientific, Inc.
$955,969
Attributed
$2,367,908
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $924.4K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,367,908 · 2
By mechanism
R42$2,117,908 · 1
SB1$250,000 · 1
Top collaborators
- Curt I Civin3 shared
- James C Sturm3 shared
Others in their field
Other Emerging Leaders on “Liquid Substance”
- Hanjoon Ryu$28,519,898
- Scott Fry$21,470,000
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Claudia L Satizabal · Boston University Medical Campus$10,721,425
- Leonard Freedman · Leidos Biomedical Research, Inc.$10,469,484
- Jeanette Coffin · Midwest Research Institute$10,204,323
Research focus
Liquid SubstanceRecoveryImmunotherapyLeukocytesMicrofluidicsProductionDesignFda ApprovedLateralLeukapheresisMalignant NeoplasmsBusinessesOutputPersonalized MedicineCostCost EffectiveDevicesCellsBloodCell TherapyCell TypeBaseAutologousSampling
Grant awards (4)
Regulatory Readiness for a Superior Microfluidic CAR-T Therapy Cell Processing System$250,000
SB1 · FY2022 · CA · contact PI
Microfluidic CAR-T Cell Processing Device$913,556
R42 · FY2020 · CA · contact PI
Microfluidic CAR-T Cell Processing Device$924,383
R42 · FY2019 · CA · contact PI
Microfluidic CAR-T Cell Processing Device$279,969
R42 · FY2018 · CA · contact PI